Morpholin-4-ium 4 methoxyphenyl (morpholino) phosphinodithioate (GYY4137) as a novel vasodilator agent

  • US 8,865,684 B2
  • Filed: 08/15/2013
  • Issued: 10/21/2014
  • Est. Priority Date: 04/24/2009
  • Status: Expired due to Fees
First Claim
Patent Images

1. A method of treating a condition associated with constriction of one or more vascular beds in an individual in need thereof comprising administering an effective amount of morpholin-4-ium 4 methoxyphenyl(morpholino)phosphinodithioate (GYY4137) or a pharmaceutically acceptable salt thereof,wherein the condition is a heart failure.

View all claims

    Thank you for your feedback